Log In
Print
BCIQ
Print
Print this Print this
 

AMG 820

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionHuman mAb that targets C-FMS
Molecular Target Colony-stimulating factor 1 receptor (CSF1R) (C-FMS) (CD115)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today